Post-Lyme Disease Syndrome (PLDS) Clinical Trial
Official title:
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome
This study will determine the effectiveness of a nutraceutical in treating the lingering effects of Lyme Disease after antibiotic treatment.
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome will be evaluated during a double blind, placebo controlled study. This study is an expansion of RLP042019 NCT04078841 Treating Post-Lyme Disease Syndrome With Acetogenins ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04078841 -
Treating Post-Lyme Disease Syndrome With Acetogenins
|
Phase 1/Phase 2 |